Graf Akcie INCY (Incyte Corp.). Diskuze k akciím INCY. Aktuální informace INCY.

Základní informace o společnosti Incyte Corp. (Akcie INCY)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 14.25B
Hodnota podniku (EV) 14.75B
Tržby 2.721B
EBITDA 532.205M
Zisk 337.638M
Růst v tržbách Q/Q 2.57 %
Růst v tržbách Y/Y 13.95 %
P/E (Cena vůči ziskům) 42.71
Forward P/E 28.38
EV/Sales 5.42
EV/EBITDA 27.71
EV/EBIT 36.22
PEG 0.88
Price/Sales 5.24
P/FCF 31.69
Price/Book 5.46
Účetní hodnota na akcii 12.05
Hotovost na akcii 8.32
FCF vůči ceně 3.16 %
Počet zaměstnanců 1,773
Tržba na zaměstnance 1534000
Profit margin -11.09 %
Operating margin 15.81 %
Gross margin 95.08 %
EBIT margin 14.97 %
EBITDA margin 19.56 %
EPS - Zisk na akcii 1.54
EPS - Kvartální růst -35.48 %
EPS - Očekávaný růst příští rok 213.04 %
Return on assets 9.36 %
Return on equity 12.66 %
ROIC -6.58 %
ROCE 12.55 %
Dluhy/Equity 0.36
Čistý dluh/EBITDA -13.97
Current ratio 3.97
Quick Ratio 3.89
Volatilita 2.43
Beta 0.68
RSI 34.93
Cílová cena analytiků 102
Známka akcie (dle analytiků) 2.10
Insider ownership 1.46 %
Institutional ownership 93.85 %
Počet akcií 220.835M
Procento shortovaných akcií 3.80 %
Short ratio 4.63 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1993
Země United States

Finanční výsledky akcie INCY

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$2,666.702$2,158.759$1,881.883$1,536.216$1,105.719$753.751
Cost Of Goods Sold$131.328$114.249$94.123$79.479$58.187$26.972
Gross Profit$2,535.374$2,044.51$1,787.76$1,456.737$1,047.532$726.779
Research And Development Expenses$2,215.942$1,154.111$1,197.957$1,326.134$581.861$479.514
SG&A Expenses$516.922$468.711$434.407$366.286$303.251$196.614
Other Operating Income Or Expenses$-66.186$-19.682$-26.173$-7.704$-17.422-
Operating Expenses$2,930.378$1,756.753$1,752.66$1,779.603$960.721$703.1
Operating Income$-263.676$402.006$129.223$-243.387$144.998$50.651
Total Non-Operating Income/Expense$31.458$84.785$-13.876$-68.903$-37.594$-43.095
Pre-Tax Income$-232.218$486.791$115.347$-312.29$107.404$7.556
Income Taxes$63.479$39.885$5.854$0.852$3.182$1.025
Income After Taxes$-295.697$446.906$109.493$-313.142$104.222$6.531
Other Income------
Income From Continuous Operations$-295.697$446.906$109.493$-313.142$104.222$6.531
Income From Discontinued Operations------
Net Income$-295.697$446.906$109.493$-313.142$104.222$6.531
EBITDA$-211.869$456.539$184.192$-191.209$203.423$95.534
EBIT$-263.676$402.006$129.223$-243.387$144.998$50.651
Basic Shares Outstanding218215212205188180
Shares Outstanding218218216205194187
Basic EPS$-1.36$2.08$0.52$-1.53$0.55$0.04
EPS - Earnings Per Share$-1.36$2.05$0.51$-1.53$0.54$0.03
# 2020 2019 2018 2017 2016 2015
Current Ratio3.73884.8344.30844.00873.6355.0139
Long-term Debt / Capital0.01230.01210.0090.01010.60830.7836
Debt/Equity Ratio0.01330.01960.00910.01471.55313.6218
Gross Margin95.075394.707794.998594.826394.737696.4216
Operating Margin-9.887718.62216.8667-15.843313.11356.7199
EBIT Margin-9.887718.62216.8667-15.843313.11356.7199
EBITDA Margin-7.94521.14829.7876-12.446818.397312.6745
Pre-Tax Profit Margin-8.708122.54966.1293-20.32859.71351.0025
Net Profit Margin-11.088520.7025.8183-20.3849.42570.8665
Asset Turnover0.74890.630.71130.66720.67480.7482
Inventory Turnover Ratio7.995610.021813.509812.261514.171215.1273
Receiveable Turnover5.53266.99066.1185.76887.4336.5859
Days Sales In Receivables65.972152.21359.660163.271849.105355.4218
ROE - Return On Equity-11.323917.19925.6851-19.203824.84633.8158
Return On Tangible Equity-12.9519.87157.0413-25.29141916.8993.8158
ROA - Return On Assets-8.30413.04174.1384-13.59966.36040.6483
ROI - Return On Investment-11.184416.99055.6341-19.01019.73180.8256
Book Value Per Share11.89712.01989.03057.71852.22120.917
Operating Cash Flow Per Share-3.83641.70582.0137-2.02441.09260.321
Free Cash Flow Per Share-4.3371.68792.2157-1.94750.61180.3481

Porovnání s konkurencí: Akcie INCY

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
INCY 42.71 0.88 13.95 % 213.04 % 12.66 % 5.46 -11.09 %
Akcie AMGN 20.99 1.66 4.87 % -2.29 % 60.57 % 12.44 28.57 %
Akcie ARDX 0.00 N/A 49.39 % 70.00 % -99.11 % 0.92 -1,245.71 %
Akcie AVEO N/A N/A -50.16 % 9.09 % -106.87 % 6.22 -591.19 %
Akcie CTIC N/A N/A N/A % 66.67 % -144.30 % 6.43 N/A %
Akcie GERN N/A N/A 1.26 % 50.00 % -49.12 % 2.22 -29,888.14 %
Akcie LLY 35.62 1.63 16.46 % 27.92 % 101.98 % 39.72 25.24 %
Akcie LGND 45.23 1.61 99.11 % -0.96 % 6.52 % 3.01 -1.60 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %

Nedávné obchody insiderů: Akcie INCY

Jméno Obchod Cena Objem
Dashyant Dhanak
EVP and Chief Scientific Officer
Option
6 Nov 2020
$65.42 $62,869
Dashyant Dhanak
EVP and Chief Scientific Officer
Option
6 Nov 2020
$65.42 $62,869
Jean Jacques Bienaime
Director
Prodej
10 Nov 2020
$83.00 $66,234
Jean Jacques Bienaime
Director
Prodej
10 Nov 2020
$83.00 $66,234
Maria E Pasquale
EVP and General Counsel
Option
11 Dec 2020
$65.36 $8,366
Maria E Pasquale
EVP and General Counsel
Option
11 Dec 2020
$65.36 $8,366
Maria E Pasquale
EVP and General Counsel
Option
11 Jan 2021
$65.36 $8,301
Maria E Pasquale
EVP and General Counsel
Option
11 Jan 2021
$65.36 $8,301
Barry P Flannelly
EVP and General Manager US
Prodej
25 Jan 2021
$100.00 $274,400
Barry P Flannelly
EVP and General Manager US
Prodej
25 Jan 2021
$100.00 $274,400
Vijay K Iyengar
EVP GPS, BD, and Licensing
Prodej
25 Jan 2021
$99.00 $506,484
Vijay K Iyengar
EVP GPS, BD, and Licensing
Prodej
25 Jan 2021
$99.00 $506,484
Steven H Stein
EVP and Chief Medical Officer
Option
25 Jan 2021
$68.62 $260,413
Steven H Stein
EVP and Chief Medical Officer
Option
25 Jan 2021
$68.62 $260,413
Yao Wenqing
EVP and Head of Discovery Chem
Option
25 Jan 2021
$73.21 $1,577,309
Yao Wenqing
EVP and Head of Discovery Chem
Option
25 Jan 2021
$73.21 $1,577,309
Dashyant Dhanak
EVP and Chief Scientific Officer
Prodej
1 Feb 2021
$90.00 $122,040
Dashyant Dhanak
EVP and Chief Scientific Officer
Prodej
1 Feb 2021
$90.00 $122,040
Maria E Pasquale
EVP and General Counsel
Option
16 Feb 2021
$65.36 $8,301
Herve Hoppenot
Chairman / CEO
Nákup
23 Feb 2021
$77.37 $1,000,007
Maria E Pasquale
EVP and General Counsel
Option
16 Feb 2021
$65.36 $8,301
Herve Hoppenot
Chairman / CEO
Nákup
23 Feb 2021
$77.37 $1,000,007

Diskuze k akciím INCY